| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.23 | 0.5 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.5 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.046 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |